Scarica l'app Stockscreener
9.43
0.53%
0.05
Dopo l'orario di chiusura:
9.43
Precedente Chiudi:
$9.38
Aprire:
$9.48
Volume 24 ore:
2,018
Relative Volume:
0.20
Capitalizzazione di mercato:
$54.95M
Reddito:
$503.40K
Utile/perdita netta:
$9.17M
Rapporto P/E:
5.2074
EPS:
1.8109
Flusso di cassa netto:
$-604.40K
1 W Prestazione:
+3.91%
1M Prestazione:
-17.86%
6M Prestazione:
-25.75%
1 anno Prestazione:
+25.96%
Intervallo 1D:
$9.29
$9.6951
Intervallo di 1 settimana:
$9.19
$9.6951
Portata 52W:
$7.10
$14.76
Daxor Corporation Stock (DXR) Company Profile
Nome
Daxor Corporation
Settore
Industria
Telefono
212-330-8500
Indirizzo
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
9.43 | 54.66M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-05-16 | Iniziato | Ascendiant Capital Markets | Buy |
Daxor Corporation Borsa (DXR) Ultime notizie
(DXR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
RSI Check: What is the long term forecast for Daxor Corporation stockEarnings Miss & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
CEO Moves: Is Daxor Corporation stock risky to hold now2026 Drop Watch & Consistent Profit Trading Strategies - baoquankhu1.vn
Insider Buying: Michael Feldschuh Acquires Additional Shares of Daxor Corp (DXR) - GuruFocus
Daxor CEO Feldschuh buys $9,070 in shares By Investing.com - Investing.com South Africa
Daxor CEO Feldschuh buys $9,070 in shares - Investing.com
DAXOR (DXR) CEO Michael Feldschuh adds 1,000 shares in open-market buy - Stock Titan
Daxor launches blood volume testing program in Ohio By Investing.com - Investing.com South Africa
Daxor Corporation Expands Customer Footprint With New BVA Program At High-Volume Ohio Cardiology Center - marketscreener.com
Daxor launches blood volume testing program in Ohio - Investing.com
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center - GlobeNewswire
Income Plays: Is Daxor Corporation vulnerable to short sellers2026 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
[N-CEN/A] DAXOR CORP SEC Filing - Stock Titan
Insider Buying: Robert Michel Acquires Shares of Daxor Corp (DXR) - GuruFocus
Michel, Daxor CFO, buys $9,900 in DXR stock - Investing.com
Michel, Daxor CFO, buys $9,900 in DXR stock By Investing.com - Investing.com India
DAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy - Stock Titan
DXR PE Ratio & Valuation, Is DXR Overvalued - Intellectia AI
Setup Watch: Will Daxor Corporation stock go up in YEARNew Guidance & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Earnings Risk: What is the target price for Daxor Corporation stock2026 Biggest Moves & High Accuracy Trade Alerts - baoquankhu1.vn
Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 - Bitget
Daxor’s Blood Volume Analysis Metric Validated as Uniquely - GlobeNewswire
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com
Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 By Investing.com - Investing.com Australia
Daxor (DXR) CMO boosts stake with 5,941-share equity grant - Stock Titan
Macro Review: What is the long term forecast for Daxor Corporation stockEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn
Institution Moves: What is the earnings history of Daxor CorporationChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Daxor Corporation to Showcase Next-Generation Portable - GlobeNewswire
Daxor to showcase next-gen portable BVA at ACC.26 session - TipRanks
Daxor (DXR) Showcases Innovative Blood Volume Analyzer at Major Cardiology Event - GuruFocus
Daxor Corporation Showcases Next-Generation Portable Blood Volume Analyzer At ACC.26 - marketscreener.com
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions - marketscreener.com
[N-CEN] DAXOR CORP SEC Filing - Stock Titan
Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha - MarketBeat
DXR: Direct blood volume analysis drives improved outcomes and rapid revenue growth in a vast market - TradingView
Daxor (DXR) Unveils Portable Blood Volume Analyzer at Critical C - GuruFocus
Daxor Corporation Showcases New Portable Blood Volume Analyzer - marketscreener.com
Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress - TipRanks
ICU blood volume test linked to 66% fewer deaths goes portable - Stock Titan
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire
Market Overview: Will Murano Global Investments Plc Equity Warrant benefit from rate cuts2026 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
What analyst consensus says on Daxor Corporation stockExit Point & Fast Moving Trade Plans - Naître et grandir
Layoff Watch: Is Daxor Corporation a turnaround storyGap Up & Safe Entry Trade Reports - baoquankhu1.vn
Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat
European Stocks Set for Mixed Opening Amid Geopolitical Tensions - Intellectia AI
DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan
Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget
Daxor reports 45% revenue growth, plans regulatory shift - Investing.com
Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com
Daxor Corporation Azioni (DXR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.06%
1.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):